![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/20 | |
A61K 38/26 | |||
A61K 31/195 | |||
A61P 3/04 | |||
A61P 3/10 |
(11) | Number of the document | 3326620 |
(13) | Kind of document | T |
(96) | European patent application number | 17204363.0 |
Date of filing the European patent application | 2011-12-16 | |
(97) | Date of publication of the European application | 2018-05-30 |
(45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
10195285 | 2010-12-16 | EP | |
201061425087 P | 2010-12-20 | US |
(72) |
BJERREGAARD, Simon, DK
SAUERBERG, Per, DK
Seier, NIELSEN, Flemming, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLIC ACID |
SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLIC ACID |